SIG | Dietary Therapies for Epilepsy: Therapy Innovations and Ketogenic Diet Mechanisms

Tuesday, December 7, 2021
-

You may need to log in to view video on this page.

OVERVIEW:

This Special Interest Group explores two areas of dietary therapy research and practice.  

COVID-19 has imposed significant difficulties on the practice of medicine, including care for epilepsy, and particularly for those who are managed on dietary therapies for epilepsy.  

This session focuses on three aspects:

  1. The practical management of dietary treatment of epilepsy utilizing remote monitoring, e-mail communication, and telemedicine. Helpful tools and potential problems are addressed 
  2. The role of gut microbiome in mediating the ketogenic diet. Our speaker reviews recent basic research and explore mechanisms by which the gut microbiome may affect epilepsy and its treatment 
  3. Presentations from research selected annual meeting posters 

Learning Objectives:

Following participation in this activity, participants will be able to: 

  • Identify appropriate candidates for remote dietary therapy monitoring 
  • Describe methods to appropriately manage patients with dietary therapy utilizing telemedicine, e-mail, and other forms of communication 
  • Explain how the gut microbiome may mediate effects of the ketogenic diet 

Program:

SIG Coordinators: Maromi Nei, MD, Angela Poff, PhD, and Elizabeth A. Felton, MD, PhD 

Chair: Mairomi Nei, MD 

Dietary Therapy During COVID-19 and Beyond | Christina Bergqvist, MD 

Interactions Between the Ketogenic Diet and Gut Microbiome in Refractory Epilepsy | Elaine Hsiao, PhD 

Selected Posters from the Annual Meeting

Uncovering Roles for the Human Gut Microbiome in Protecting Against Pediatric Refractory Epilepsy | Gregory Lum, BS

Status Epilepticus Treatment by Metabolic Modulators |Daria Skwarzynska 

Type of Genetic Variant in SCN1A and Response to KD | Lila Worden, MD

Activity Type
Special Interest Group
Credit
Non-CME
Format
On-demand
Career Stage
Early Career (typically 0-5 years from completion of training)
Mid-Career (typically 6-15 years from completion of training)
Senior (typically >15 years from completion of training)
Audience
Advanced Practice Providers
Clinicians
Fellows/Trainees
Nurses
Pharmacists
Scientists/Researchers
Demographic
Clinical
First-time Attendees
Research
Young Professionals